A substance abuse screening, performed outdoors the purview of the Division of Transportation (DOT), analyzes organic samples for the presence of illicit substances and/or prescription drugs being misused. These panels typically embrace, however usually are not restricted to, testing for substances resembling amphetamines, cannabinoids (THC), cocaine, opiates, and phencyclidine (PCP). Some expanded panels might also embrace checks for benzodiazepines, barbiturates, methadone, and propoxyphene. The particular substances examined can fluctuate based mostly on the employer’s or group’s coverage and the chosen testing laboratory.
These screenings are useful instruments for employers aiming to keep up a protected and productive work atmosphere, contributing to diminished office accidents and improved worker morale. Traditionally, the rise in substance abuse within the workforce has pushed the implementation of those screenings, mirroring societal issues relating to drug use. The advantages prolong past security and productiveness, encompassing potential reductions in healthcare prices and authorized liabilities related to drug-related incidents.